STRATA Skin Sciences (SSKN) Other financing activities (2012 - 2023)

STRATA Skin Sciences' (SSKN) quarterly Other financing activities came in at $62000.0 in Q3 2023, down 97.35% quarter-over-quarter from $2.3 million in Q4 2018.

STRATA Skin Sciences (SSKN) Other financing activities (2012 - 2023) Analysis & Trends

STRATA Skin Sciences has disclosed Other financing activities across 6 years of filings, most recently posting $62000.0 for Q3 2023.

  • Other financing activities for Q3 2023 came in at $62000.0, changed N/A year-over-year; the trailing twelve-month figure through Dec 2024 was $62000.0 (changed 0.0% YoY), and the FY2023 annual result was $97000.0, changed N/A from the prior year.
  • Other financing activities came in at $62000.0 for Q3 2023 at STRATA Skin Sciences, down from $2.3 million in the prior quarter.
  • In the past five years, Other financing activities ranged from a high of $62000.0 in Q3 2023 to a low of $62000.0 in Q3 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn
10 STRATA Skin Sciences - - 5.61 Mn

Historic Data

Download Data
DateValue
Sep 30, 2023 62,000.00
Sep 30, 2023 62,000.00
Dec 31, 2018 2.34 Mn
Dec 31, 2018 2.34 Mn
Jun 30, 2018 -202,000.00
Jun 30, 2018 -202,000.00
Mar 31, 2018 202,000.00
Mar 31, 2018 202,000.00
Sep 30, 2015 34,000.00
Sep 30, 2015 34,000.00
Dec 31, 2014 -8,000.00
Dec 31, 2014 -8,000.00
Mar 31, 2013 -15.75 Mn
Mar 31, 2013 -15.75 Mn
Sep 30, 2012 105,056.00
Sep 30, 2012 105,056.00
Jun 30, 2012 194,649.00
Jun 30, 2012 194,649.00
Mar 31, 2012 4,293.00
Mar 31, 2012 4,293.00